Delivery Order SPE2DR25D3301-SPE2DR26F20QS
- Not listed
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $8,048.54 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count units) on January 7, 2026, with an ultimate completion date of January 8, 2026. The order carries no set-aside designation and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $10,756.42 to AmerisourceBergen Drug Corp for the supply of Jardiance 10mg tablets (90-count) on November 18, 2025, with completion scheduled for December 16, 2025. This firm fixed-price, non-set-aside contract will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order valued at $1,894.92 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count). This firm fixed-price contract, effective January 12, 2026, with an ultimate completion date of January 13, 2026, was competitively awarded with no set-aside designation. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a task order issued under...
- The Defense Logistics Agency awarded a delivery order valued at $6,899.94 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count packages) on December 16, 2025, with completion scheduled for December 17, 2025. The award was competitively procured under a firm fixed-price contract structure with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $9,732.24 on January 7, 2026, for the supply of Jardiance 25 mg tablets (90-count packages). The contract is a firm fixed-price delivery order with no set-aside designation, awarded by the Defense Logistics Agency (DLA), the Department of Defense's supply chain management organization responsible for medical procurement. Performance will be completed...
- The Defense Logistics Agency awarded a delivery order valued at $11,643.53 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count packaging) with a completion date of December 16, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a continuation of AmerisourceBergen's substantial pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order valued at $36,477.05 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count packaging) on September 12, 2025, with an ultimate completion date of September 15, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen is a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order valued at $5,288.73 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count units) on December 29, 2025, with completion expected by December 30, 2025. This non-competitive, firm fixed-price delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The pharmaceutical will be...
- The Defense Logistics Agency awarded a delivery order valued at $8,921.73 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) on January 7, 2026, with completion expected by January 8, 2026. This firm fixed-price delivery order was competitively awarded without a set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as...
- The Defense Logistics Agency awarded a delivery order valued at $9,297.17 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count packages) on August 4, 2025, with an ultimate completion date of August 5, 2025. This competitively awarded, firm fixed price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- SPE2DR25D3301Indefinite Delivery Contract
- SPE2DR25D3301-SPE2DR26F20QSDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $9,616.38 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count supply) on January 12, 2026, with an ultimate completion date of January 13, 2026. This firm fixed-price, non-set-aside contract is being performed at the contractor's location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's parent organization, Cencora, Inc., which holds a significant Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2031, serving as the comprehensive vehicle for pharmaceutical and medical supply deliveries to support military healthcare programs globally. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor that supplies a comprehensive range of medications, vaccines, and medical devices across multiple therapeutic domains to military and veteran healthcare systems. As a subsidiary of Cencora, Inc., the company has demonstrated consistent capability to meet federal procurement requirements through open competition, with its contract portfolio encompassing specialty medications, brand-name and generic drugs, and medical supplies. This particular delivery order for Jardiance, a diabetes medication, represents routine pharmaceutical procurement supporting the Department of Defense's medical supply chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.6k | 1/11/26 |